News

Find News

Filter articles

Showing 2711 to 2720 of 2987 results

Sun and Novartis settle on Gleevec

US15-05-2014

Novartis and Sun Pharma’s US subsidiary have settled litigation related to cancer drug Gleevec (imatinib mesylate) in the US, the companies announced today (May 15).

Janssen sues to halt Mylan’s Concerta generic

US14-05-2014Legal developments

Johnson & Johnson’s pharmaceuticals subsidiary Janssen has sued Mylan to stop it launching a generic version of Concerta (methylphenidate hydrochloride).

Valeant agrees to license Acanya in Actavis settlement

US13-05-2014Legal developments

Canadian pharmaceutical company Valeant announced yesterday (May 12) that it had settled all litigation related to its acne treatment Acanya (clindamycin phosphate and benzoyl peroxide) with Actavis.

INTA 2014: Pharma concerned about plain packaging's advance

Australia, Switzerland12-05-2014

The pharmaceutical industry, as well as food and alcoholic drink manufacturers, could be under pressure from the spread of plain and standardised packaging, delegates at INTA's annual meeting in Hong Kong were told today, May 12.

“Dolly the sheep” clones cannot be patented

US12-05-2014

The US Court of Appeals for the Federal Circuit has ruled that mammals made using the cloning method that created Dolly the sheep are not patent eligible.

GE accused of infringing hygiene monitoring product

US09-05-2014

UK-based medical technologies manufacturer Hill-Rom has sued General Electric (GE), claiming that the company infringes three patents covering hygiene monitoring systems.

Acura settles Oxecta dispute with Ranbaxy

US08-05-2014Legal developments

Acura Pharmaceuticals and Ranbaxy have agreed to settle their patent infringement litigation related to painkiller Aversion (oxycodone hydrochloride), once marketed by Pfizer under its registered trademark Oxecta.

FTC weighs in on “no-authorised-generic” antitrust case

US07-05-2014

The US Federal Trade Commission (FTC) has filed an amicus brief in an antitrust case that concerns a “no-authorised-generic” settlement between Teva and GlaxoSmithKline (GSK).

Allergan sues Aurobindo over eye drop generic

US06-05-2014Legal developments

Allergan, along with Japan-based Senju and Kyorin have sued Indian pharma Aurobindo for infringing claims in the Japanese pharmaceutical companies’ reexamined US patent 6,333,045.

Bayer buys Merck’s consumer care arm for $14.2bn

Germany, US06-05-2014Mergers & acquisitions

Bayer AG has agreed to buy New Jersey-based Merck’s consumer care business for $14.2 billion, the companies announced today (May 6).

Showing 2711 to 2720 of 2987 results

LSIPR